Wendy Taylor, MPP

Wendy Taylor, MPP, left Lawrence to study Public Policy at Duke University and Harvard University's Kennedy School of Government then spent her career developing and implementing policies and programs to serve the public, often the uhderserved. Her most recent work which she founded is with the Center for Accelerating Innovation and Impact at USAID. This organization accelerates the development, introduction and scale up of priority global health innovations; key projects include innovation Grand Challenges - Fighting Ebola, Combating Zika and Future Threats and Saving Lives at Birth. Through these challenges she catalyzed $140 million in new investments and a pipeline of groundbreaking innovations that are already beginning to scale and save lives. Additional career highlights include: Spearheaded innovative finance deals including a $100 Million backed by a USAID guarantee proving bridge financing to accelerate the purchase of health commodities; incentives to stimulate R&D $10 Million for Advance Purchase Commitments for Zika diagnostics.

Created multiple public private partnerships/licensing deals, including with Coca-Cola, GSK, Bill & Melinda Gates Foundation, DuPont & Mccann Health to strengthen health systems and/or accelerate access to life-saving commodities.

Managed and coordinated the activities of Malaria No More's (MNM) international affiliates and identified/evaluated opportunities for expansion of MNM to other countries; led global advocacy for MNM, identified financing support funding for malaria control.

Founded Bio Ventures for Global Health (BVGH), established the Board, led initial growth, strategy & operations, Executive Director first two years; developed policy/advocacy agenda centered on new market incentives to stimulate industry investment in global health R&D. Raised nearly $15 million in funding from the Bill & Melinda Gates Foundation, Rockefeller Foundations and corporate donors.

Offered a business approach to global health solutions, revealing opportunities in global health including development of the TB Vaccine Business Case.

Planned & organized Biotechnology Industry Organization (BIO) and the Gates Foundation Partnering for Global Health Forum 2002 -first to bring together biotech industry & global health- community to tackle challenge of addressing diseases of the developing world.

Led BIO's discussions with the FDA to secure the successful reauthorization of the Prescription Drug User Fee Act (PDUFA Ill); developed BIO's policy proposals, established & led BIO task force to address the reorganization of biologics within the FDA.

Served as Special Assistant to several 0MB officials under the Clinton White House; developed & coordinated policy positions with 0MB, White House and agency officials in FDA, CDC & NIH. Negotiated agreement between FDA & Department of Defense regarding administration of investigational drug to US troops in combat situations.

Negotiated with agency officials and Congress to enact FDA Modernization Act (FDAMA), worked closely with FDA to ensure successful implementation of numerous FDAMA regulations. Led 0MB coordination of Federal food safety activities, contributed significantly to the Administration's achievements under the Food Safety Initiative.

Negotiated significant changes to various labeling regulations, i.e. FDA's over-the-counter and prescription drug labeling rules.